Filing Details

Accession Number:
0001415889-22-011459
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-16 19:51:07
Reporting Period:
2022-11-15
Accepted Time:
2022-11-16 19:51:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1159036 Halozyme Therapeutics Inc. HALO Biological Products, (No Disgnostic Substances) (2836) 880488686
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1910662 Nicole Labrosse C/O Halozyme Therapeutics, Inc.
11388 Sorrento Valley Road
San Diego CA 92121
Svp, Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-11-15 4,635 $53.82 4,410 No 4 S Direct
Common Stock Disposition 2022-11-15 365 $53.69 4,045 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct